MARIA DOLORES MAURICIO AVIÑO-rekin lankidetzan egindako argitalpenak (6)

2019

  1. Changes in chemokines and chemokine receptors expression in a mouse model of alzheimer’s disease

    International Journal of Biological Sciences, Vol. 15, Núm. 2, pp. 453-463

2017

  1. Neuronal effects of sugammadex in combination with rocuronium or vecuronium

    International Journal of Medical Sciences, Vol. 14, Núm. 3, pp. 224-230

2016

  1. Effects of ranolazine on astrocytes and neurons in primary culture

    PLoS ONE, Vol. 11, Núm. 3

2015

  1. Astrocytes protect neurons from Aβ1-42 peptide-induced neurotoxicity increasing TFAM and PGC-1 and decreasing PPAR-γ and SIRT-1

    International Journal of Medical Sciences, Vol. 12, Núm. 1, pp. 48-56

  2. WIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid β1-42 effects on astrocytes in primary culture

    PLoS ONE, Vol. 10, Núm. 4

2013

  1. Sugammadex, a neuromuscular blockade reversal agent, causes neuronal apoptosis in primary cultures

    International Journal of Medical Sciences, Vol. 10, Núm. 10, pp. 1278-1285